BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Patient Worthy - ECPv5.12.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Patient Worthy
X-ORIGINAL-URL:https://patientworthy.com
X-WR-CALDESC:Events for Patient Worthy
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200319T183000
DTEND;TZID=America/New_York:20200319T193000
DTSTAMP:20260626T154412
CREATED:20191210T222542Z
LAST-MODIFIED:20191211T144639Z
UID:160105-1584642600-1584646200@patientworthy.com
SUMMARY:Richmond\, VA Live Event: CIDP Patient Speaker Program
DESCRIPTION:Speakers: William Blouin MSN\, ARNP\, CPNP\nLorry Callaghan\nTo register for this live event\, click here.  \nFor information on CIDP Webinar Wednesdays with this PW collaborator\, click here. And to register\, click here. \nAcknowledgment: This event post is sponsored by CSL Behring and is promoted through the Patient Worthy Collaborative Content program. We only publish content that embodies our mission of providing relevant\, vetted and valuable information to the rare disease community.
URL:https://patientworthy.com/event/richmond-va-event-cidp-patient-speaker-program/
LOCATION:Maggiano’s Little Italy\, 11800 W Broad St\, Richmond\, VA\, 23223\, United States
CATEGORIES:Chronic Inflammatory Demyelinating Polyneuropathy
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200319T193000
DTEND;TZID=America/New_York:20200319T203000
DTSTAMP:20260626T154412
CREATED:20200304T150152Z
LAST-MODIFIED:20200413T185520Z
UID:167254-1584646200-1584649800@patientworthy.com
SUMMARY:Takeda's Alunbrig Web Event
DESCRIPTION:Speakers: Jason A. Salganick\, MD & Larissa C.\, Patient Ambassador\nJoin us to learn more about ALK+ non-small cell lung cancer (NSCLC) and ALUNBRIG (brigatinib) as a treatment option for ALK+ NSCLC. Hear a healthcare professional speak about ALK+ NSCLC and ALUNBRIG (brigatinib). Hear the story and treatment experience of a person living with ALK+ NSCLC.\nTo register for this webinar\, click here.\nAcknowledgment: This event post is sponsored by Takeda and is promoted through the Patient Worthy Collaborative Content program. We only publish content that embodies our mission of providing relevant\, vetted and valuable information to the rare disease community.
URL:https://patientworthy.com/event/alunbrig-web-event-nsclc/
LOCATION:VA
CATEGORIES:ALK+ Non-Small Cell Lung Cancer
END:VEVENT
END:VCALENDAR